|
Cancer Drug Delays Aging in Mice
2009-07-09 16:31:00 From Wired Top Stories: A drug approved for treating cancer also can extend the life of elderly mice. Though the drug is not likely to be tested in humans because of its immunosuppressant effects, it suggests that it is possible to slow aging, even if treatment is started later in
FDA Approves First Canine Cancer Drug: Pfizer's Palladia
2009-06-05 01:07:00 One of the most common types of canine cancer and the number one cause of canine death, cutaneous mast cell tumor, has been treated with steroids and antihistamines and various human oncology drugs for years. Finally, a specific oncology drug for these specific canine cancers has been developed and approved for veterinary use: Palladia (toceranib phosphate) produced by Pfizer Animal Health Inc.
UPDATE 1-Alfacell's cancer drug fails trial, shares sink - Reuters
2008-05-30 12:38:00 May 28 (Reuters) - Biotechnology company Alfacell Corp (ACEL.O: Quote , Profile , Research ) said a late-stage trial of its drug, Onconase, for a rare cancer affecting organ linings failed, knocking... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
By: Engineers Voice
Dabur gets USFDA’s nod for cancer drug
2008-05-28 15:44:00 For More Logon to : http://investorline.co.in/blogs-/news/ Dabur gets USFDA’s nod for cancer drug New Delhi, May 20: Domestic pharmaceutical company Dabur Oncology Plc has received the approval from US Food and Drug Administrator (USFDA) for selling ‘Mitoxantrone Hydrochloride’, an injectable used in the treatment of prostate cancer. According to the information available on USFDA’s website, company has received ...
Potential New Cancer Drug Identified by Scientists
2008-03-11 15:15:00 We all know that Cancer claims a lot of lives and many of us have lost relatives to the disease, I know I have. Scientists from the University of Michigan Comprehensive Cancer Centre have been able to accomplish what a lot of scientists have been trying to do for years; they have found a cancer drug ...
By: Product Reviews
Scientists Identify New Potential Cancer Drug
2008-03-09 22:19:00 Scientists at the University of Michigan Comprehensive Cancer Center are able to accomplish what cancer researchers have been trying to for years -- finding a potent cancer drug which doesn't kill normal cells as it does tumor cells. Technorati Tags: cancer medical research discovery
Novel Cancer Drug launched by Zydus Cadila
2008-02-18 09:29:00 Good news for Cancer Patients: Major Indian pharma company Zydus Cadila has launched a novel cancer treatment product " Nudoxa " A novel drug delivery system product (NDDS). This drug is used in a mode of cancer treatment called chemotherapy. This drug is used in various forms of cancer specially breast and ovarian cancer.Zydus Cadila has patent right for India and South Africa and has applied for patents in US, EU, and Japan.Nudoxa is manufactured by Zydus-BSV Paharma Pvt. Ltd and marketed by Zydus Biogen.Cadila said that this drug has reduced toxicity and side effects.
New Breast Cancer Drug Does Wonders
2008-02-17 00:13:00 The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy. These are the encouraging findings in an interim report from HERA, an ongoing large, international clinical trial of Herceptin, being published today ...
By: 中国糖尿病网
New anti-cancer drug maybe from sea algae
2008-02-12 06:57:00 CM NEWS, UCSD release - A team of researchers has identified a potent new anti-cancer drug isolated from a toxic blue-green algae found in the South Pacific. The properties of somocystinamide A (ScA) are described in a paper that will be published online in Proceedings of the National Academy of Science. The research team was spearheaded by Dennis Carson M.D., professor of medicine and director of the Rebecca and John Moores UCSD Cancer Centre at the University of California, San Diego (UCSD). What is cyanobacteria? Cyanobacteria, also known as Cyanophyta or blue-green algae, is a phylum of bacteria that obtain their energy through photosynthesis. They are a significant component of the marine nitrogen cycle and an important primary producer in many areas of the ocean, but are also found on land. Cyanobacteria are proving to be a source of a large number of novel organic compounds with biological activity. Among the many compounds found and characterised to date, many are toxic and ...
NEW CANCER DRUG MAY BE ON THE WAY
2008-01-25 11:36:00 New method is stronger yet less harmful than most chemoJohns Hopkins researchers say they have discovered a previously unsuspected way to kill cancer cells that could lead to stronger yet less harmful cancer drugs. Their findings appear in the Early Edition of the Proceedings of the National Academy of Sciences."A major hang-up in cancer chemotherapy is the toxicity caused by DNA disruption of cell division throughout the body. Our research suggests that drugs like cisplatin and novobiocin kill cells as much from this newly discovered mechanism as any other mechanism of cell death," said Solomon H. Snyder, M.D., a professor of neuroscience at Hopkins."Targeting this new mechanism in drug design might make for therapies with fewer side effects."Link to complete story: http://www.consumeraffairs.com/-news04/2008/01/jhu_cancer.html~-Sandy G.
By: ATYOURSERVICE
Study calls for weighing pros and cons of prostate cancer drug before use
2008-01-21 10:43:00 Researchers at the University of Texas Southwestern Medical Center say that men should weigh the potential benefits as well as side effects of a drug called finasteride before relying on it as a preventative medicine for prostate cancer. The researchers say that they have analysed data gathered by the National Cancer Institute’s Prostate Cancer Prevention Trial (PCPT), which began in October 1993 to test whether finasteride could prevent prostate cancer in men 55 years of age and older. When the trial stopped early in June 2003, an analysis showed that finasteride could reduce the risk of developing prostate cancer by 25 per cent. However, the latest analysis of the PCPT data indicates that cost effectiveness and quality of life issues associated with taking the drug are not clear-cut. The PCPT data show that in addition to preventing prostate cancer, finasteride also reduces urinary tract symptoms associated with benign prostatic hyperplasia. It a...
By: B4U India
Current Breast Cancer Drug Looks Promising for Mania re Bipolar Disorder
2007-11-16 17:12:00 Here is another article I received via a news feed. This looks promising! A current drug for breast cancer may have promising results for people suffering from bipolar disorder when they are in a manic state. Check out this article: Channel 8 Drug Article Commentary is welcome!
MAYO CLINIC SEES NEW HOPE IN BREAST CANCER DRUG
2007-11-06 15:50:00 New drug may induce cancer cells to self-destructA Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.The study, which was done in mouse models, is featured on the cover of the November issue of Cancer Research.The National Cancer Institute reports that of 240,510 breast cancer diagnoses each year, about 178,480 of those women will have invasive cancer that has spread.In breast cancer, the cancer commonly lodges in the bone, destroying it in a debilitating and painful process called osteolysis. Osteolysis can lead to bone fractures that release excess calcium into the blood causing patients to feel tired or even lose consciousness.The drug 2-methoxyestradiol -- or 2ME2, trade name Panzem -- is currently in clinical trials by other researchers as a treatment for various cancers. Mayo Clinic recently completed a clinical tri...
By: ATYOURSERVICE
HOPE OVER TUMOR-KILLING SKIN CANCER DRUG
2007-10-04 02:44:00 Treatment improves survival by causing melanoma cells to self-destructDoctors are hopeful about a new drug to treat skin cancer by causing tumor cells to self-destruct by overloading them with oxygen.Unlike regular cells, which can control their oxygen levels relatively easily, cancer cells have trouble balancing the levels.With the new drug STA-4783, doctors may be able to overload the cancer cells with oxygen-containing chemicals to the point where the cells cannot cope and simply die off, according to research presented Wednesday at a meeting of the European Cancer Organization in Barcelona.Link to complete story: http://www.msnbc.msn.com/id/209-92619/ ~Sandy G.
By: ATYOURSERVICE
Cancer drug found effective against Alzheimer's disease - China Post
2007-08-31 07:08:00 Cancer drug found effective against Alzheimer's diseaseChina Post, Taiwan -30 minutes agoTaiwan researchers have proved during rodent testing that a widely used cancer drug is also effective against Alzheimer's disease, with clinical experiments … More: continued here
Liver cancer drug - Nexavar
2007-08-29 05:54:00 Nexavar, a pharmaceutical drug designed to treat liver cancer, had a late-stage trial recently cut off and disbanded. But, the reason is not what you think: the trial was ended because the results of patients using the drug were all so positive that a further continuation of the trial was not needed. The trial (which was ...
By: cancer war
Cancer Drug: Medicare?s Restrictions on Anemia Drugs
2007-08-04 04:41:00 Medicare has eased up on some of its proposed restrictions on the use of popular anemia drugs made by Amgen and Johnson & Johnson. The decision, announced late yesterday, could provide some relief for the two companies, which have already experienced steep drops in sales of the drugs because of concerns that the products might ...
By: Cancer war
Prostate cancer drug - finasteride and sexual dysfunction
2007-07-28 15:59:00 Men taking finasteride, a drug used to prevent prostate cancer, need not worry about sexual dysfunction side effects, according to a study from the Southwest Oncology Group. Physicians usually warn patients that sexual dysfunction is a possible side effect when discussing finasteride. This study came out of the Prostate Cancer Prevention Trial, a large National Cancer ...
By: cancer war
Prostate Cancer Drug And Sexual Function In Most Men
2007-07-22 15:27:00 Men and their physicians need not hesitate to use a drug proven effective in preventing prostate cancer out of concern that it is likely to cause sexual dysfunction, say authors of a study conducted by the Southwest Oncology Group. The authors, who surveyed more than 17,000 men 55 and older for seven years, reported their ...
By: Cancer war
Commentary Highlights Impact Of Food-cancer Drug Interactions
2007-07-19 06:00:00 A commentary in the Journal of Clinical Oncology, urges researchers to explore an intriguing approach to reduce the dose and therefore the cost, of oral targeted cancer therapies. Read more at silkboard
New Targeted Cancer Drugs Using Ultrasound
2007-07-14 06:04:00 A new targeted drug delivery method uses ultrasound to image tumors, while also releasing the drug from “nanobubbles” into the tumor, according to a study published online July 10 in the Journal of the National Cancer Institute. Cancer drugs can be targeted to tumors by delivering them in packets of nanoparticles, then releasing them with ...
By: cancer war
Merck and Ariad are working for new cancer drug
2007-07-14 06:02:00 It appears pharmaceutical giant Merck is wanting to get a larger piece of the cancer drug pie. The company iaspartnering with Ariad Pharmaceuticals to develop a new cancer treatment (in an experimental stage) with the potential to make the smaller Ariad over a billion greenbacks. Genentech’s Avastin has been selling like hotcakes lately, and the world ...
By: cancer war
Cancer Drug: Trabectedin (Made From Sea Squirt) Offers Cancer Hope
2007-07-12 14:56:00 A compound derived from the lowly sea squirt fights a deadly type of soft-tissue cancer and holds promise for ovarian cancer as well. The drug, generically known as trabectedin and formerly called ecteinascidin or ET-743, is branded as Yondelis by maker PharmaMar. It was originally made from a sea squirt — the translucent, siphon-like organism also ...
By: cancer war
Cancer drug enhances long-term memory
2007-07-10 13:48:00 A drug used to treat cancer has been shown to enhance long-term memory and strengthen neural connections in the brain, according to a new study by UC Irvine scientists.In the study with mice, scientists found that histone deacetylase (HDAC) inhibitors – currently used in clinical trials to attack cancerous tumors – relaxes the protein structure that organizes and compacts genomic DNA, allowing for easier activation of genes involved in memory storage. This finding suggests that HDAC inhibitors could boost memory in humans and – because of the way they work – be therapeutic for people with Alzheimer’s and Huntington’s diseases and Rubenstein-Taybi syndrome.“We have demonstrated for the first time that HDAC inhibitors applied directly to the hippocampus enhance memory and synaptic plasticity in the brain, and we now know a molecular mechanism through which these enhancements occur,” said Marcelo Wood, assistant professor in the Department of Neurobiology and Behavior a...
By: Science News
?Longboat Delivery System? And Anti-cancer Drugs
2007-07-05 07:19:00 Scientists are reporting development of carbon nanotubes as a “longboat delivery system” that shows potential for addressing shortcomings that have hindered development of more generally applicable platinum-based anticancer drugs. These include analogues of the widely used and extremely potent drugs cisplatin, carboplatin, and oxaliplatin. The report is scheduled for the July 11 issue of the ...
By: cancer war
Lung cancer drug: Tarceva and Iressa
2007-07-01 02:57:00 Tarceva (erlotinib) and Iressa (gefitnib) are both agents targeted against the EGFR pathway. This pathway is involved in cell growth and replication and when mutated or altered, excessive replication of cells can occur. These agents reduce the uncontrolled replication and growth of cancer cells by blocking mutated EGFR pathways. According to an article published in ...
By: Cancer war
Five new cancer drugs from GlaxoSmithKline
2007-06-26 15:43:00 Five new cancer treatments are in the works and could be available for use as early as 2010, thanks to GlaxoSmithKline, PLC, the world’s second largest drug company. The drugs will treat a range of different cancers — one will be cervical cancer — and are known as cervarix, pazopanib, promacta, rezonic, and ofatumumab. “Over the next ...
By: Cancer war
Cancer Research: Potential New Cancer Drug
2007-06-22 16:26:00 Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors. These findings were published in the ...
By: Cancer war
Ixabepilone - new breast cancer drug
2007-06-19 16:37:00 A new and experimental breast cancer drug, ixabepilone, has passed initial health regulator scrutiny and from all reports, an approval (or not) could come later this year, perhaps in October. The FDA’s decision on this new drug will be given with a “priority review,” which means the regular 10 to 12 months review period will be ...
By: Cancer war
Cancer drugs and treatments are too expensive
2007-06-18 16:10:00 It’s one of the major setbacks of capitalism: people stand to make a buck off of everything, even medicine that can save the life of many. So when it comes to Cancer, it’s no secret that the drugs and treatments are expensive — and someone is definitely making money off of it. But before you ...
By: Cancer war
Study shows a cancer drug may enhance long-term memory
2007-06-06 17:48:00 A drug used to treat cancer has been shown to enhance long-term memory and strengthen neural connections in the brain, according to a new study by UC Irvine scientists. In the study with mice, scientists found that histone deacetylase (HDAC) inhibitors — currently used in clinical trials to attack cancerous tumors — relaxes the protein structure ...
By: Cancer war
kidney cancer drug - sorafenib
2007-06-06 17:33:00 Liver cancer is one of the toughest cancers to battle, and it claims close to half a million people each year as sufferers. Some positive news on the liver cancer front was discovered recently, as cancer specialists said that the drug sorafenib was seen to give liver cancer patients long lifespans compared to study participants ...
By: Cancer war
New Kidney Cancer Drug (Torisel, temsirolimus) has been approved by FDA
2007-05-31 16:50:00 The U.S. Food and Drug Administration on Wednesday gave its approval to a new drug called Torisel (temsirolimus) for treating renal cell carcinoma, a type of advanced kidney cancer. The approval of the drug, an enzyme inhibitor made by Wyeth Pharmaceuticals, was based on a study that showed use of the drug prolonged survival of ...
By: Cancer war
Setback for pancreatic cancer drug
2007-04-12 09:17:00 NEW YORK, April 11: A new U.S. study found Erbitux did not significantly prolong lives of people with pancreatic cancer.
By: newkerala.com
Holographic Images Use Shimmer to Show Cellular Response to Anticancer Drug
2007-03-07 01:29:03 From Purdue University - News Service: The response of tumors to anticancer drugs has been observed in real-time 3-D images usin...
An accidental discovery may lead to the development of a new cancer drug
2007-02-06 15:48:00 SpiritIndia.com: Katherine Schaefer, Lawrence Saubermann and researchers believe they have discovered by chance a new way to fight colorectal cancer, and potentially cancers of the esophagus, liver and skin.Early work shows that a group of compounds called Peroxisome_proliferator-activat-ed_receptor-gamma (PPAR-gamma) inhibitors may have an unexpected cancer-fighting effect, according to research published in the journal International Cancer Research. Furthermore, the new studies suggest that PPAR-gamma inhibitors act through some of the same mechanisms as the blockbuster chemotherapy Taxol, but with key differences.While studying whether compounds known to affect PPAR-gamma could play a role in inflammatory bowel diseases, a team at the University of Rochester Medical Center found that medium-to-high doses of PPAR-gamma inhibitor killed colorectal cancer cell lines. Despite the compound's class name, the anti-cancer effect has nothing to do with the ability of the compounds to inhi... |
|
 |
|
 |
